Search
for
Sort by
Research 30 of 688
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- FINASTERIDE INHIBITS 5?-REDUCTASE ACTIVITY IN HUMAN DERMAL FIBROBLASTS: PREDICTION OF ITS THERAPEUTIC APPLICATION IN ANDROGEN-RELATED SKIN DISEASES
- Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
- Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions
- An update of the pathogenesis of frontal fibrosing alopecia: What does the current evidence tell us?
- 5α-Reduced glucocorticoids: a story of natural selection
- Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Male androgenetic alopecia (Part II)
- Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Post-finasteride Syndrome: A Review of Current Literature
- Chapter 23. Therapeutic Control of Androgen Action
- TSPO ligand etifoxine attenuates LPS-induced cognitive dysfunction in mice
- Effects of 5-?±-Reductase Inhibitor (Finasteride) on Per Operative Blood Loss in Patients with BPH undergoing TURP
- Clinical use of 5α-reductase inhibitors
- Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Otherwise Healthy Males and Females in an Open Label Pilot Study
- Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana
- Synthesis of Spiro[cyclohexane-1,2?-[2H]indene] derivatives as inhibitors of steroid 5?-reductase
- Patent Evaluation: Δ-4,6-Steroids as Potent 5α-Reductase Inhibitors
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Long-term Oral Administration of 5α-reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors